One of the main benefits touted by Lilly is that Strattera is the only ADHD drug on the market that is not a stimulant, meaning users are less likely to abuse it. The makers of Adderall and Concerta ...

INDIANAPOLIS, May 8 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY - News) announced today that the United States Food and Drug Administration (FDA) has ...

The Food and Drug Administration (FDA) is advising health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and ...

The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...

FDA approves Eli Lilly's Strattera for ADHD maintenance By Michael Kitchen Published: May 8, 2008 at 8:52 a.m. ET Share ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Strattera (atomoxetine, Eli Lilly) to treat children and adults with attention ...

(CN) - The Federal Circuit extended an order temporarily blocking generic versions of Eli Lilly & Co.'s Strattera while the pharmaceutical giant appeals a ruling invalidating its U.S. patent for the ...

WASHINGTON - The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention ...

This article will describe the drug Strattera so that you know more about how it can help you overcome ADHD symptoms and other aspects It is used to treat the distractibility, impulsivity, and ...

The calls started coming several months ago: When will it be here? When will you have it? For some parents the wait seemed interminable. They kept the phones ringing until the release date finally ...

BOSTON (MarketWatch)-Eli Lilly said early Thursday that at the request of the Food and Drug Administration, it is adding a warning to the label of its attention-deficit drug Stattera advising it may ...

May 11, 2005 — The U.S. Food and Drug Administration (FDA) approved in February revisions to safety labeling to advise that use of atomoxetine HCl may be linked rarely to severe liver injury, and that ...